Summary
LAUSANNE, Switzerland–(BUSINESS WIRE)–Timeline (Amazentis SA), the Swiss longevity biotech company behind Mitopure (Urolithin A), today announced major scientific milestones reinforcing its position as a leader in clinically researched longevity supplements, targeting the three critical unmet nee…
Source: BioSpace
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
